Back to Search
Start Over
Improvement of Libman-Sacks endocarditis after combination of warfarin and immunosuppressive therapy
- Source :
- Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology.
- Publication Year :
- 2019
- Publisher :
- Turkish Society of Cardiology, 2019.
-
Abstract
- Antiphospholipid syndrome (APS) is a clinical disorder that creates an increased risk of arterial or venous thrombotic events or pregnancy-associated complications and includes the presence of autoantibodies against negatively charged phospholipids. This syndrome is often associated with systemic autoimmune diseases, such as systemic lupus erythematosus (SLE). Libman-Sacks endocarditis is a form of non-bacterial thrombotic endocarditis and is infrequently seen in APS. There are few data documenting the echocardiographic response of APS valve disease to medical treatment. This is an unusual case of a young female patient with SLE and APS who had chorea and non-bacterial thrombotic aortic valve endocarditis. Echocardiography revealed that the vegetation had receded after a combination of warfarin and immunosuppressive therapy.
- Subjects :
- medicine.medical_specialty
Lupus erythematosus
business.industry
Warfarin
Autoantibody
Chorea
medicine.disease
Libman–Sacks endocarditis
immune system diseases
Antiphospholipid syndrome
Internal medicine
medicine
Cardiology
Endocarditis
medicine.symptom
Young adult
skin and connective tissue diseases
Cardiology and Cardiovascular Medicine
business
medicine.drug
Subjects
Details
- ISSN :
- 10165169
- Database :
- OpenAIRE
- Journal :
- Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
- Accession number :
- edsair.doi...........5630e39fcd296a0cc75db1310031ea6c
- Full Text :
- https://doi.org/10.5543/tkda.2019.29213